Novavax reported $0 in Loan Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Astrazeneca AZN:US 27.15B 1.66B
AstraZeneca AZN:LN 27146M 1659M
Dynavax Technologies DVAX:US $ 221.03M 0.27M
Genocea Biosciences GNCA:US $ 2.95M 1.2M
Geron GERN:US $ 50.18M 0.35M
GlaxoSmithKline GSK:LN 18784M 10442M
Mannkind MNKD:US $ 366.99M 8.14M
Moderna Inc MRNA:US $ 641M 5M
Novartis NVS:US $ 23784M 589M
Pain Therapeutics PTIE:US $ 0M 0M
Peregrine Pharmaceuticals PPHM:US $ 141.67M 0.14M
Sarepta Therapeutics SRPT:US $ 1100.87M 2.03M